Latest Breaking News On - Tourmaline bio daily - Page 6 : comparemela.com

Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Truist Financial

Truist Financial initiated coverage on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The firm issued a buy rating and a $43.00 target price on the stock. TRML has been the topic of several other reports. Piper Sandler assumed coverage on shares of […]

New yorkUnited statesPiper sandlerCaley casteleinAaron kantoffSecurities exchange commissionTourmaline bio company profileTourmaline bio incTruist financialTourmaline bioFree reportDirector caley casteleinExchange commissionDirector aaron kantoffGet free reportThyroid eye disease

Tourmaline Bio (TRML) vs The Competition Financial Comparison

Tourmaline Bio (TRML) vs The Competition Financial Comparison
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTourmaline bio incTourmaline bioGet free reportGiven tourmaline bioThyroid eye diseaseTourmaline bio daily

Truist Financial Begins Coverage on Tourmaline Bio (NASDAQ:TRML)

Analysts at Truist Financial began coverage on shares of Tourmaline Bio (NASDAQ:TRML – Get Free Report) in a report released on Friday, Marketbeat.com reports. The brokerage set a “buy” rating and a $43.00 price target on the stock. Truist Financial’s target price indicates a potential upside of 160.92% from the company’s previous close. TRML has […]

New yorkUnited statesAaron kantoffSandeep chidambar kulkarniPiper sandlerSecurities exchange commissionTourmaline bio incTourmaline bio company profileTruist financialTourmaline bioGet free reportChidambar kulkarniExchange commissionDirector aaron kantoffThyroid eye diseaseTourmaline bio daily